Effect of consumption of tomato juice enriched with N-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women

European Journal of Nutrition

Volumn 51, Issue 4, 2012, Pages 415-424

  Garcia Alonso F J ^a   Jorge Vidal, V ^a   Ros, G ^a   Periago, M J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Antioxidants; Cardiovascular diseases (CVD); Homocysteine; ICAM 1; Lipid oxidation; PUFAs; Tomato juice; VCAM 1

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LOW DENSITY LIPOPROTEIN; LYCOPENE; OMEGA 3 FATTY ACID; PHENOL DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; FRUIT JUICE; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NORMAL HUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE BLIND PROCEDURE; TOMATO JUICE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIOXIDANTS; BEVERAGES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; FEMALE; FOOD, FORTIFIED; FRUIT; HOMOCYSTEINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPIDS; LYCOPERSICON ESCULENTUM; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SINGLE-BLIND METHOD; SPAIN; VASCULAR CELL ADHESION MOLECULE-1;

LYCOPERSICON ESCULENTUM;

EID: 84864682973     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0225-0     Document Type: Article

References (59)

1. Das UN (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and, and cardioprotective molecules. Lipids Health Dis 7:37-55
2. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M (2006) ACE enzyme inhibitors, anti-arrhytmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 27(13):1610-1619
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics-2010 Update. A report from the American Heart Association. Circulation 121:e46-e215
4. Maas R, Böger RH (2003) Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl 4:5-17 (Pubitemid 38234489)
5. Bhatnagar D, Durrington PN (2003) Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57:305-314 (Pubitemid 36700716)
6. Nishida C, Uauy R, Kumanyika S, Shetty P (2004) The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7:245-250 (Pubitemid 38294520)
7. De Caterina R, Massaro M (2005) Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and proinflammatory genes. J Membr Biol 206:103-116 (Pubitemid 43199144)
8. Calder PC, Yaqoob P (2009) Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 35:266-272
9. Lavie CJ, Milani RV, Mehra MR, Ventura HO (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (JACC) 54:585-594
10. Patel JV, Tracey I, Hughes EA, Lip G Y H (2000) Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc Health Risk Manag 5:801-810
11. De Roos B, Mavromatis Y, Brouwer IA (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 158:413-428
12. Vrablik M, Prusikova M, Snejdrlova M, Zlatohlavek L (2009) Omega-3 fatty acids and cardiovascular disease risk. Do we understand the relationship? Physiol Res 58((Suppl 1)):S19-S26
13. He K (2009) Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease-Eat fish or take fish oil supplement? Prog Cardiovasc Dis 52:95-114
14. World Health Organization (1985) Energy and protein requirements. Technical Report Series, No. 724. Report of a Joint FAO/WHO/UNU Expert Consultation. World Health Organization. Geneva
15. Baghurst K (2005) Executive summary of nutrient reference values for Australia and New Zealand including recommended dietary intakes. Commonwealth department of health and ageing, Australia. Ministryof health, New Zealand. National Health and Medical Research. Council. http://www.nhmrc.gov. au/publi cations/synopses/n35syn. htm
16. Kris-Etherton PM, Grieger JA, Etherton TD (2009) Dietary reference intakes for DHA and EPA. Prostag Leukotr Ess 81:99-104
17. Wallace JM, McCabe AJ, Robson PJ, Keogh MK, Murray CA, Kelly PM, Marquez-Ruiz G, McGlynn H, Gilmore WS, Strain JJ (2000) Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil. Ann Nutr Metab 44:157-162
18. Whelan J, Rust C (2006) Innovative dietary sources of n-3 fatty acids. Ann Rev Nutr 26:75-103
19. Kolanowsky W, Swiderski F, Berger S (1999) Possibilities of fish oil application for food products enrichment with omega-3 PUFA. Int J Food Sci Nutr 50:39-49 (Pubitemid 29078200)
20. Metcalf RG, James MJ, Mantzioris E, Cleland LG (2003) A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur J Clin Nutr 57:1605-1612 (Pubitemid 38016594)
21. Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V (2008) Food products as vehicles for n-3 fatty acid supplementation. Can J Diet Pract Res 69:203-207
22. Periago MJ, García-Alonso FJ, Jacob K, Olivares AB, Bernal MJ, Iniesta MD, Martínez C, Ros G (2008) Bioactive compounds, folates and antioxidant properties of tomatoes (Lycopersicum esculentum) during vine ripening. Int J Food Sci Nutr 12:1-15
23. Garcia-Alonso FJ, Bravo S, Casas J, Pérez-Conesa D, Jacob K, Periago MJ (2009) Changes in antioxidant compounds during the shelf life of commercial tomato juices in different packaging materials. J Agric Food Chem 57:6815-6822
24. Rao AV (2002) Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med 227:908-913 (Pubitemid 35340346)
25. Wilcox JK, Catignani GL, Lazarus S (2003) Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 43(1):1-18 (Pubitemid 38552309)
26. Iniesta MD, Pérez-Conesa D, García-Alonso FJ, Ros G, Periago MJ (2009) Folate content in tomato (Lycopersicum esculentum). Influence of cultivar, ripeness, year of harvest and pasteurization and storage temperatures. J Agric Food Chem 57:4739-4745
27. Aguilar B, Rojas JC, Collados MT (2004) Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolys 18:75-87 (Pubitemid 40485113)
28. Jacob K, Periago MJ, Böhm V, Berruezo GR (2008) Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr 99:137-146 (Pubitemid 350286147)
29. Castelli WP (1988) Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 4(Suppl A):5A-10A
30. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Method Enzymol 52:302-310
31. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolf SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenilphosphine. Anal Biochem 220:403-409 (Pubitemid 2109729)
32. Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA (1996) Antioxidant activities of carotenes and xanthophylls. Fed Eur Biochem Soc Lett 384:240-242 (Pubitemid 26125229)
33. Benzie I F F, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239:70-76
34. Esteve MJ, Farré R, Frígola A, López JC, Romera JM, Ramírez M, Gil A (1995) Comparison of voltammetric and high performance liquid chromatographic methods for ascorbic acid determination in infant formulas. Food Chem 52:99-102
35. MacCrehan WA (1990) Determination of retinol, a-tocopherol and b-carotene in serum by liquid chromatography. Method Enzymol 189:172-181
36. Baró L, Fonollá J, Peña JL, Martínez- Férez A, Lucena A, Jiménez J, Boza JJ, López-Huertas E (2003) n-3 fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 22:175-182 (Pubitemid 36372462)
37. Carrero JJ, Fonollá J, Mart JL, Jimenez J, Boza JJ, Lopez-Huertas E (2007) Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma-C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr 137:384-390 (Pubitemid 46213454)
38. Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S, Soriguer FC (2006) Effects of milk enriched with x-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25:581-587 (Pubitemid 44070584)
39. Raghu B, Venkatesan P (2008) Effect of n-3 fatty acid supplementation on blood glucose, lipid profile and cytokines in humans: a pilot study. Ind J Clin Biochem 23:85-88 (Pubitemid 351866258)
40. Fuhrman B, Elis A, Aviram M (1997) Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Bioph Res Co 233(3):658-662 (Pubitemid 27217707)
41. Schmidt EB, Lervang HH, Varming K, Madsen P, Dyeberg J (1992) Lon-term supplementation with n-3 fatty acids, I: effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Inv 52:221-228
42. Ridker P (2003) Expert opinions: clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369 (Pubitemid 36158034)
43. López-García E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134:1086-1811
44. Shen YC, Chen SL, Wang CK (2007) Contribution of tomato phenolics to antioxidation and down-regulation of blood lipids. J Agric Food Chem 55:6475-6481
45. Thorlaksdottir AY, Skuladottir GV, Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM, Eyfjord JE, Jonsson JJ, Hardardottir I (2006) Positive association between plasma antioxidant capacity and n-3 PUFA in red blood cells from women. Lipids 41:119-126
46. Erdogan H, Fadillioglu E, Ozgocmen S, Sogut S, Ozyurt B, Akyol O, Ardicoglu O (2004) Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostag Leukotr Ess 71:149-152 (Pubitemid 38903059)
47. Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteinelowering vitamin supplements. Semin Thromb Hemost 26:341-348
48. Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC (2002) Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303:158-162
49. Ueland PM, Refsum H, Beresford SA, Wollset SE (2000) The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72:324-332 (Pubitemid 30623491)
50. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case control studies. Int J Epidemiol 31:59-70 (Pubitemid 34284901)
51. Huang T, Wahlqvist ML, Li D (2010) Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and nRNA expression involved in methionine metabolism. Nutrition 26:112-119
52. Grundt H, Nilsen D W T, Mansoor MA, Hetland O, Nordoy A (2003) Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomized double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33:88-95 (Pubitemid 37449283)
53. Chi Z, Melendez AJ (2007) Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. Cell Adh Migr 1:171-175
54. Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, Calder PC (2001) Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) 100:91-100 (Pubitemid 32057813)
55. Liu X, Qu D, He F, Lu Q, Wang J, Cai D (2007) Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia Pac J Clin Nutr 16:244-248 (Pubitemid 46524608)
56. Blum A, Moni M, Khazim K, Peleg A, Blum N (2007) Tomatorich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 30(2):E70-E74 (Pubitemid 47535695)
57. Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012-17017 (Pubitemid 27289806)
58. Mestas J, Ley K (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18:228-232
59. Rizzo M, Kotur-Stevuljevic J, Berneis K, Spinas G, Rini BG, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Vekic J (2009) Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 153:217-223